This FTSE 100 share is down 10% this week: here’s why

FTSE 100 share Smiths Group is falling on bid news. Roland Head explains what’s happened and when he might consider buying.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 share Smiths Group (LSE: SMIN) is down by almost 10% so far this week. This drop seems to have been triggered by Monday’s news that the company has agreed a $2.5bn deal to sell its healthcare division, Smiths Medical.

This split has been expected for a while and should leave this engineering group more focused on its industrial technology businesses. But shareholders don’t seem entirely happy. In this piece, I want to find out why the Smiths share price is falling — and whether I should buy the stock.

What’s happened?

Smiths Group has agreed to sell its Smiths Medical business to US private equity group TA Associates for $2.3bn (£1.7bn), plus a further $0.2bn dependent on future performance. Smiths will also retain a 30% stake in Smiths Medical, giving it the opportunity to benefit from future growth.

Shareholders are expected to receive a “significant” amount of this cash, although Smiths Group plans to retain some of the money to invest in the growth of its remaining businesses.

Management says that this deal is better than any of the other offers it’s received for Smiths Medical. However, Smiths’ falling share price suggests to me that not all of its shareholders agree with this view.

Why are Smiths shares falling?

The Smiths Medical deal was announced after the London market closed on Monday. So the 8% fall seen on Tuesday morning represents investors’ initial reaction to the sale. It’s quite a big drop for a FTSE 100 share — why aren’t shareholders happy?

I can see a couple of possible explanations. Investors may think Smiths Medical is being sold too cheaply. I’m not convinced of this. The medical business is being sold at a valuation of 9.7x EBITDA earnings. This seems fair to me, given recent slow growth.

Another possibility is that shareholders are disappointed that management has ruled out the idea of floating Smiths Medical as an independent business. I have more sympathy with this view. If I was a Smiths shareholder, I might have been interested in owning shares in Smiths Medical. I believe it could have long-term growth potential as an independent business.

Should I buy this FTSE 100 share?

One thing I’m sure of is that getting rid of the medical business is the right decision for Smiths. It just didn’t really fit with the group’s remaining operations, which all have a more industrial focus.

For example, Smiths’ companies make airport security scanners, industrial gas leak detectors, and hoses and connectors for gas and aerospace applications.

My sums suggest that the profitability of the remaining group could improve when the medical business is sold. I’d also expect the tighter focus to make it easier for new CEO Paul Keel to generate fresh growth.

Smiths has been on my watch list for a while. I’ve not bought the stock because I’ve felt it was a little expensive, given the group’s fairly average profit margins. If profitability improves — or the shares fall a little further — I may consider buying. Right now, however, I’m not quite convinced.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How much would I need to invest in income shares to earn £300 a month?

What kind of lump sum would be required to earn £300 a month by taking advantage of some of the…

Read more »

Investing For Beginners

Up 31% in a month, could this FTSE 250 stock be getting bought out?

Jon Smith takes a look at speculation that's pushing the share price of a FTSE 250 share higher and considers…

Read more »

Investing Articles

Here’s how I’d follow Warren Buffett to start building passive income in 2025

Ben McPoland highlights one FTSE 250 firm with a strong competitive edge that he thinks can continue rewarding investors with…

Read more »

Investing Articles

Burberry shares: undervalued FTSE gems that are ready to rocket?

Burberry shares soared at the beginning of the week as the takeover rumour mill went into overdrive. Is Paul Summers…

Read more »

US Stock

Here are the latest share price forecasts for S&P 500 giant Amazon

Amazon has generated monster gains for investors over the last decade. And Wall Street analysts believe the S&P 500 stock…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

2 high-yield FTSE 250 shares I’d buy today — and 1 that I’d avoid

UK markets have felt some volatility after last week’s Budget and the FTSE 250 was no stranger to it. Our…

Read more »

Investing Articles

3 reasons the Rolls-Royce share price could soar over the next decade

Sustainable aviation fuel, narrow-body aircraft, and small nuclear reactors could all keep the Rolls-Royce share price climbing over the next…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Here’s how much income I’d get if I invested my entire £20k ISA in cheap BT shares

BT shares are on the up but still cheap, while the FTSE 100 telecoms stock offers a good yield too.…

Read more »